Sputnik to combat new Covid strain India, says vaccine developer Gamaleya Center
Tribune News Service
New Delhi, April 28
The Sputnik V coronavirus vaccine gives enough antibodies to combat the virus’ Indian strain, the vaccine developer and director of the Gamaleya Center Alexander Gintsburg has told TASS ahead of the arrival of the first Russian shipments of the vaccine to India.
“If necessary, we will combat the Indian strain by high titers of antibodies triggered by the Sputnik V vaccine. As a rule, it generates antibodies 20, 30, 80 times as much as necessary to neutralize the biggest amount of the virus in an infected organism. Sputnik V will be effective against the Indian strain,’’ he said.
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now
